Re-evaluation of quality control guidelines for gatifloxacin and garenoxacin (BMS284756) when susceptibility testing Haemophilus influenzae and Streptococcus pneumoniae
- 11 June 2003
- journal article
- research article
- Published by Elsevier in Diagnostic Microbiology and Infectious Disease
- Vol. 46 (2) , 147-150
- https://doi.org/10.1016/s0732-8893(03)00039-7
Abstract
No abstract availableKeywords
This publication has 4 references indexed in Scilit:
- Activity and spectrum of BMS 284756, a new des-F (6) quinolone, tested against strains of ciprofloxacin-resistant Gram-positive cocciDiagnostic Microbiology and Infectious Disease, 2001
- Antibacterial Spectrum of a Novel Des-Fluoro(6) Quinolone, BMS-284756Antimicrobial Agents and Chemotherapy, 2000
- In vitro antibacterial spectrum of a new broad-spectrum 8-methoxy fluoroquinolone, gatifloxacinJournal of Antimicrobial Chemotherapy, 2000
- Comparative antimicrobial activity of gatifloxacin tested against Streptococcus spp. including quality control guidelines and etest method validationDiagnostic Microbiology and Infectious Disease, 1999